LIVE VIEW · RAREUltragenyx Pharmaceutical Inc.BiotechnologyRARE research Sign up to open the full interactive terminal, save boards, and get alerts
RARE · Live chart
Loading live chart
RARE · Smart-money compositeas of Jul 30
+26LONGsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
RARE · Recent signals
Q2-2025: Beat consensus by 11.7% - EPS $-1.17 vs $-1.3247 estimateMEDIUMLONGJun 3
Q1-2026: Missed consensus by 19.5% - EPS $-1.84 vs $-1.5399 estimateMEDIUMSHORTJun 3
Q3-2025: Missed consensus by 43.7% - EPS $-1.81 vs $-1.2592 estimateMEDIUMSHORTJun 3
Q4-2025: Missed consensus by 15.8% - EPS $-1.29 vs $-1.1138 estimateMEDIUMSHORTJun 3
RARE · Institutional holdersas of 2026Q1
TWO SIGMA INVESTMENTS, LP$46.2M+420.2%
MILLENNIUM MANAGEMENT LLC$37.1M+101.2%
D. E. Shaw & Co., Inc.$26.4M+265.8%
MILLENNIUM MANAGEMENT LLC$20.3M+787.6%
Point72 Asset Management, L.P.$18.7Mn/a
RENAISSANCE TECHNOLOGIES LLC$11.8M+53.4%
TWO SIGMA INVESTMENTS, LP$9.8Mn/a
TWO SIGMA INVESTMENTS, LP$9.8M+30.0%
Live alerts on RARE
Live alerts on RAREGet pinged the moment insiders, congress, or 13F funds move on RARE.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for RARE.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock